Device
QPOP
QPOP is a medical device with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
1(33%)
Phase Distribution
Ph phase_1
2
67%
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 1Safety & dosage
2(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Other(2)
Detailed Status
unknown2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 1
Trials by Phase
Phase 12 (100.0%)
Trials by Status
unknown267%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingphase_1
Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI
NCT05381038
unknownphase_1
Quadratic Phenotypic Optimisation Platform (QPOP) Utilisation to Enhance Selection of Patient Therapy Through Patient Derived Organoids in Breast Cancer
NCT05177432
unknown
Q-GAIN (Using Qpop to Predict Treatment for GAstroIntestinal caNcer)
NCT04611035
Clinical Trials (3)
Showing 3 of 3 trials
NCT05381038Phase 1
Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI
NCT05177432Phase 1
Quadratic Phenotypic Optimisation Platform (QPOP) Utilisation to Enhance Selection of Patient Therapy Through Patient Derived Organoids in Breast Cancer
NCT04611035
Q-GAIN (Using Qpop to Predict Treatment for GAstroIntestinal caNcer)
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3